Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Completed Initiated Jul 2, 2019 (7 years ago)

OCuSOFT Tetravisc Tetracaine HCl 0.5% Sterile Anesthetic

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

OCuSOFT Tetravisc Tetracaine HCl 0.5% Sterile Anesthetic, 5 mL, Mfd. for OCuSOFT, Inc. PO Box 429 Richmond, TX 77406-0429 Made in USA, NDC 54799-505-05

Affected NDC 54799-0505-05

Compare with the code on your package — it is the most precise check available.

Drug: Tetracaine

Recalling firm
Altaire Pharmaceuticals, Inc.
NDC code
54799-505-05
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0446-2020 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now completed, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Tetracaine recalls

See all
Class III · Low risk

LET Gel

Product Mix-up: Incorrect Product Formulation

Terminated Labeling / mix-up Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop NDC 73271-1003-1 D-0140-2024
Class II · Moderate risk

TETRACAINE 1% Tetracaine HCI Injection

Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.

Terminated Sterility / contamination Vitae Enim Vitae Scientific, Inc. NDC 42494-437-10 D-0741-2022

Other recalls by Altaire Pharmaceuticals, Inc.

All 2019 recalls